VINBLASTINE for Haematological malignancy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where VINBLASTINE was used for Haematological malignancy.
Most Reported Side Effects for VINBLASTINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 508 | 9.4% | 125 | 148 |
| Febrile neutropenia | 498 | 9.2% | 62 | 285 |
| Neutropenia | 416 | 7.7% | 74 | 175 |
| Drug ineffective | 302 | 5.6% | 68 | 62 |
| Product use in unapproved indication | 265 | 4.9% | 66 | 73 |
| Disease progression | 262 | 4.9% | 58 | 21 |
| Pyrexia | 259 | 4.8% | 26 | 166 |
| Neuropathy peripheral | 258 | 4.8% | 10 | 32 |
| Nausea | 215 | 4.0% | 25 | 127 |
| Vomiting | 172 | 3.2% | 24 | 105 |
| Malignant neoplasm progression | 170 | 3.2% | 45 | 35 |
| Second primary malignancy | 170 | 3.2% | 86 | 34 |
| Thrombocytopenia | 167 | 3.1% | 57 | 62 |
| Anaemia | 165 | 3.1% | 26 | 58 |
| Hodgkin's disease | 165 | 3.1% | 19 | 48 |
Other Indications for VINBLASTINE
Hodgkin's disease (2,866)
Product used for unknown indication (380)
Langerhans' cell histiocytosis (164)
Transitional cell carcinoma (116)
Bladder cancer (94)
Chemotherapy (86)
Non-hodgkin's lymphoma (59)
Hodgkin's disease nodular sclerosis (54)
Lymphoma (54)
Diffuse large b-cell lymphoma (52)
Other Drugs Used for Haematological malignancy
RITUXIMAB (144)
CYCLOPHOSPHAMIDE (97)
FLUDARABINE (93)
BUSULFAN (80)
LENALIDOMIDE (71)
IBRUTINIB (62)
DOXORUBICIN (61)
BEVACIZUMAB (55)
GENOXAL INYECTABLE (49)
MYCOPHENOLATE (49)